Immediate Impact
1 by Nobel laureates 3 from Science/Nature 50 standout
Citing Papers
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
2022 Standout
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
2020 Standout
Works of Bas van Vlijmen being referenced
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study
2018
Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia
1993
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bas van Vlijmen | 147 | 175 | 43 | 96 | 14 | 526 | |
| K Weiss | 202 | 81 | 87 | 17 | 13 | 639 | |
| So Jung Yang | 21 | 180 | 6 | 27 | 17 | 493 | |
| Karen Van Nuys | 59 | 53 | 19 | 44 | 23 | 558 | |
| Armen Zakharyan | 56 | 24 | 36 | 313 | 13 | 641 | |
| Fulvia Baldassarre | 44 | 85 | 25 | 78 | 19 | 644 | |
| María Daca-Álvarez | 172 | 65 | 50 | 42 | 18 | 585 | |
| Ken Wong | 221 | 113 | 100 | 23 | 21 | 614 | |
| Carlos Alatorre | 20 | 127 | 4 | 37 | 17 | 603 | |
| Lonneke Timmers | 292 | 72 | 131 | 12 | 29 | 583 | |
| Kevin O’Malley | 20 | 86 | 73 | 51 | 15 | 519 |
All Works
Login with ORCID to disown or claim papers
Loading papers...